As the generics pharmaceuticals business model evolves, the industry faces many of the same challenges as those of the traditional big pharma. Consequently, generic drug companies may find that the key to continued growth will be breaking with tradition and recruiting and retaining seasoned big pharma executives. But, it cuts both ways, and big pharma may find that the expertise of generic drug executives accustomed to leaner budgets and product cycles is the tonic they need.
As the business evolves, what will successful leadership in the generics industry look like in the next five years? To learn more, the authors interviewed numerous executives at the world's largest top generics companies and found that while these executives are keen to point out critical differences in management and leadership styles, the business challenges are similar and professional crossover opportunities are immense.